This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Grazoprevir

Merck & Co., Inc.

Drug Names(s): MK5172, MK-5172a

Description: MK-5172 is a second generation HCV NS3/4A protease inhibitor.

Grazoprevir is also being developed in a fixed dose combination with elbasvir, seen here.


Grazoprevir News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug